DD D&D PHARMATECH
Dead / Abandoned — Abandoned — failure to respond (as of 21 Dec 2023)
What this means for you
This application is over — abandoned 21 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97120139
- Mark type
- Word mark
- Filed
- 11 Nov 2021
- Abandoned
- 21 Nov 2023
- Attorney of record
- Todd S. Bontemps
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Medical and scientific research in the field of cancer, neurological diseases, fibrotic diseases, metabolic diseases, cancer, ischemia, and ophthalmic diseases and disorders
Owner
- D&D Pharmatech, Inc., Gyeonggi-do, KR
Prosecution history
- 21 Dec 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 21 Dec 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 21 Dec 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 16 Aug 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 16 Aug 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 20 May 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 May 2023 — NON-FINAL ACTION E-MAILED
- 20 May 2023 — NON-FINAL ACTION WRITTEN
- 23 Feb 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Feb 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Feb 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Aug 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Aug 2022 — NON-FINAL ACTION E-MAILED
- 29 Aug 2022 — NON-FINAL ACTION WRITTEN
- 23 Aug 2022 — ASSIGNED TO EXAMINER